1Rao VU,Spinale FG.Controlling myocardial matrix remodeling:implications for heart failure[].Cardiology Review.1999
2Bini A,Mann KG,Kudryk BJ,et al.Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis[].Arteriosclerosis and Thrombosis.1999
3Li YY,Feldman AM,Sun Y,et al.Differential expression of tissue inhibitors of metalloproteinases in the failing human heart[].Circulation.1998
4Tyagi SC,Kumar S,Voelker DJ,et al.Differential gene expression of extracellular matrix components in dilated cardiomyopathy[].Journal of Cellular Biochemistry.1996
5Thomas CV,Coker ML,Zellner JL,et al.Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy[].Circulation.1998
6Roten L,Nemoto S,Simsic J,et al.Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinase-type 1 (TIMP-1) on left ventricular geometry and function in mice[].Journal of Molecular and Cellular Cardiology.2000
7Li YY,McTiernan CF,Feldman AM.Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells[].Cardiovascular Research.1999
8Cleutjens JP.The role of matrix metalloproteinases in heart disease[].Cardiovascular Research.1996
9Segura AM,Luna RE,Horiba K,et al.Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan′s syndrome[].Circulation.1998
10Spinale FG,Coker ML,Thomas CV,et al.Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function[].Circulation Research.1998
